Skip to main content

Ryals Leaves Paradigm s Board

NEW YORK, May 16 - John A. Ryals has resigned from Paradigm Genetics' board of directors, the company said today, adding that "all outstanding issues" related to his ousting as president and CEO in February "have been resolved."

"We truly appreciate all that John Ryals has done for Paradigm," Steven Burrill, the board's chairman, said in a statement. "His leadership and vision helped propel us to where we are today. I am glad we were able to resolve all outstanding issues amicably."

Burrill was widely implicated as being the architect of Ryals' dismissal, leading the former chief to consider suing the firm.

Burrill added: "The CEO search ... is advancing according to schedule. We expect to have identified a final candidate within the next 60 days."

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.